This invention relates to stabilizing adjacent vertebrae of the spine by inserting an intervertebral spacer, and more particularly an intervertebral spacer that is stabilized.
The vertebral or spinal column (spine, backbone) is a flexible assembly of vertebrae stacked on top of each other extending from the skull to the pelvic bone which acts to support the axial skeleton and to protect the spinal cord and nerves. The vertebrae are anatomically organized into four generalized body regions identified as cervical, thoracic, lumbar, and sacral; the cervical region including the top of the spine beginning in the skull, the thoracic region spanning the torso, the lumbar region spanning the lower back, and the sacral region including the base of the spine ending with connection to the pelvic bone. With the exception of the first two cervical vertebrae, cushion-like discs separate adjacent vertebrae, i.e. intervertebral discs.
The stability of the vertebral column during compression and movement is maintained by the intervertebral discs. Each disc includes a gel-like center surrounded by a fibrous ring. The gel-like center, i.e. nucleus pulposus, provides strength such that the disc can absorb and distribute external loads and contains a mixture of type II-collagen dispersed in a proteoglycan matrix. The fibrous ring, or annulus fibrosus, provides stability during motion and contains laminated rings of type-I collagen. Thus, the annulus fibrosis and the nucleus pulposus are interdependent, as the annulus fibrosis contains the nucleus pulposus in place and the nucleus pulposus aligns the annulus fibrosus to accept and distribute external loads. The integrity of the composition and structure of the intervertebral disc is necessary to maintain normal functioning of the intervertebral disc.
Many factors can adversely alter the composition and structure of the intervertebral disc, such as normal physiological aging, mechanical injury/trauma, and/or disease, resulting in impairment or loss of disc function. For example, the content of proteoglycan n the nucleus pulposus declines with age, thus, it follows that the ability of the nucleus pulposus to absorb water concurrently declines. Therefore, in normal aging the disc progressively dehydrates, resulting in a decrease in disc height and possible de-lamination of the annulus fibrosus. Mechanical injury can tear the annulus fibrosis allowing the gel-like material of the nucleus pulposus to extrude into the spinal canal and compress neural elements. Growth of a spinal tumor can impinge upon the vertebrae and/or disc potentially compressing nerves.
Bones of the spine, and bony structures, generally, are susceptible to a variety of weaknesses that can affect their ability to provide support and structure. Weaknesses in bony structures have numerous potential causes, including degenerative diseases, tumors, fractures, and dislocations. Advances in medicine and engineering have provided doctors with a plurality of devices and techniques for alleviating or curing these weaknesses.
In some cases, the spinal column, in particular, requires additional support in order to address such weaknesses. One technique for providing support is to insert a spacer between adjacent vertebrae.
In accordance with an embodiment of the disclosure, a spacer for separating bone of a joint may be provided. The spacer may comprise a first endplate configured to engage a first bone of the joint. The spacer may further comprise a second endplate configured to engage a second bone of the joint. The spacer may further comprise tissue engaging projections, wherein the tissue engaging projections are moveable from a retracted position to a deployed position. The spacer may further comprise an actuation subassembly that extends between the first endplate and the second endplate, wherein the actuation subassembly comprise a drive nut, a drive screw coupled to the drive nut, and a cam frame coupled to the drive screw, wherein the cam frame is disposed between the first endplate and the second endplate to engage the tissue engaging projections.
In accordance with an embodiment of the disclosure, a method of separating bones of a joint may be provided. The method may comprise inserting a spacer between bones of the joint. The method may further comprise translating a cam frame along a longitudinal axis of the spacer, wherein tissue engaging projections ride along cam slots formed in lateral sides of the cam frame such that translation of the cam frame drives the tissue engaging projections to extend from endplates of the spacer and engage the bones of the joint.
These drawings illustrate certain aspects of some examples of the present invention, and should not be used to limit or define the invention.
Embodiments are directed to a spacer that may be inserted between two adjacent bony surfaces to promote the fusion of bony surfaces. After insertion, the spacer may be stabilized by deployment of body tissue engaging projections which may engage adjacent body tissue to prevent migration and/or tipping of the spacer prior to fusion occurring. Although intended to be useful with any adjacent bony surface in which fusion is desired, the spacer may advantageously be applied to insertion between two adjacent vertebral bodies in any section of the spine, including the cervical, thoracic, lumbar, and sacral vertebral sections. More than one spacer may be implanted within the body, for example between successive or separated vertebrae, between adjacent vertebrae. The use of multiple spacers is particularly advantageous for patients whose back pain is not limited to a localized area, or for patients whose localized damage has progressed to other areas of the spine.
The spacer and methods for its insertion can be used in a treatment protocol for any of a wide variety of conditions in a patient involving diseased or damaged bony structures. The patient can be a human being. Additionally, it is contemplated that the spacer may be useful in veterinary science for any animal having adjacent bony structures to be fused. Body tissue engaging projections may be retracted during insertion of spacer. After the spacer has been inserted, body tissue engaging projections may be deployed, for example. Although the spacer is exemplified herein for use in the spine, the spacer is contemplated for fusion of any bony structures. While the spacers are described herein using several varying embodiments, the spacers are not limited to these embodiments. An element of one embodiment may be used in another embodiment, or an embodiment may not include all described elements.
With reference now to
Spacer 100 forms a distal end 106 which may be inserted first into the body, and which can be tapered to facilitate insertion between body tissues. Spacer 100 also forms a proximal end 108, to which a spacer insertion device (e.g. 190 shown on
Turning now to
In some embodiments, endplates 102 may further comprise through openings 138. Through openings 138 may form an opening in endplates 102 that extends from outer facing surface 124 to inner facing surface 128. The through opening 138, in an exemplary embodiment, may be sized to receive bone graft or similar bone growth inducing material and further allow the bone graft or similar bone growth inducing material to be packed in a central opening 140 in cam frame 116 (best seen on
With specific reference to
As seen in
Endplates 102 may additionally, or alternatively, be resilient, so that they may conform to bony surfaces, forming a more stable support platform. Accordingly, endplates 102 can be fabricated from a polymeric material, a naturally resilient material, or a resilient metal, for example a shape memory alloy, or any other resilient biocompatible material of sufficient strength and durability for separating bones within the body.
Turning now to
In some embodiments, cam slots 162 may be formed in lateral frame sides 154. As illustrated three cam slots 162 may be formed in each of lateral frame sides 154. However, it should be understood that more or less than three cam slots 162 may be used. The number of cam slots 162 generally may correspond to the number of body tissue engaging projections 110. At least a portion of body tissue engaging projections 110 may be disposed in a corresponding one of cam slots 162. By way of example, each of body tissue engaging projections 110 may include a protuberance, such as ridge 164 (best seen on
Turning now to
As illustrated, actuation subassembly 104 may comprise cam frame 116, drive screw 134, and drive nut 114. Cam frame 116 may be displaced relative to endplates 102 by rotation of drive nut 114 which in turn moves drive screw 134 and cam frame 116 along spacer longitudinal axis 112. In some embodiments, rotation of drive nut 114 may cause cam frame 116 to translate a path along spacer longitudinal axis 112. A spacer insertion device (e.g., 190 on
Embodiments of drive nut 114 may also include a nut through bore 176, which may be threaded as best seen on
In some embodiments, drive screw 134 may be secured in drive nut 114 at one end and be secured to cam frame 116 at another end. Drive screw 134 may include a retainer groove 188. As illustrated, retainer groove 188 may be disposed at an opposite end of drive screw 134 from threaded portion 178. Drive screw 134 may extend into opening 156 in cam frame 116. One or more screw retaining plates 160 may inserted into retaining slots 158 to engage drive screw 134. For example, screw retaining plates 160 may engage retainer groove 188 so that drive screw 134 may be retained in opening 156.
Referring now to
Referring now to
Embodiments of spacer 100 shown on
Referring now to
In some embodiments, drive screw 134 may comprise a threaded portion 178 at one end and a clevis portion 212 at another end. Threaded portion 178 may secure drive screw 134 to drive nut 114. Cam frame 116 may comprise lateral sides 126 in which cam slots 162 may be formed. Drive screw 134 may be pivotally engaged with cam frame 116 to pivot about a vertical axis 214, substantially perpendicular to spacer longitudinal axis 112. Pin 216 may pass through openings 217 in clevis portion and pass through slot 220 in proximal frame end 150 to secure drive screw 134 to cam frame 116. In some embodiments, drive screw 134 may pivot about pin 216. In the embodiment shown in
In some embodiments, actuation subassembly 104 may further comprise a pivot housing 218. Drive nut 114 may be coupled to pivot housing 218. For example, first ring 180, such as a washer, and second ring 182, such as a c-ring, may be retained on extension 184 of drive nut 114. First ring 180 and second ring 182 may also interact with corresponding grooves in through bore 221 of pivot housing 218 to retain drive nut 114 thereto. Pivot housing 218 may include a tool engagement 219, which may be a slot or otherwise formed. Tool engagement 219 may engage a corresponding engagement of spacer insertion device (e.g., 190 on
In some embodiments, spacer 100 may further comprise a spacer body 222. As best seen on
Referring now to
In some embodiments, spacer 100 may be fabricated using any biocompatible materials known or hereinafter discovered, having sufficient strength, flexibility, resiliency, and durability for the patient, and for the term during which the device is to be implanted. Examples include but are not limited to metal, such as, for example titanium and chromium alloys; stainless steel, polymers, including for example, PEEK or high molecular weight polyethylene (HMWPE); and ceramics. There are many other biocompatible materials which may be used, including other plastics and metals, as well as fabrication using living or preserved tissue, including autograft, allograft, and xenograft material. Portions or all of the spacer 100 may be radiopaque or radiolucent, or materials having such properties may be added or incorporated into the spacer 100 to improve imaging of the device during and after implantation. Any surface or component of a spacer 100 may be coated with or impregnated with therapeutic agents, including bone growth, healing, antimicrobial, or drug materials, which may be released at a therapeutic rate, using methods known to those skilled in the art.
In some embodiments, spacer 100 may be formed using titanium, or a cobalt-chrome-molybdenum alloy, Co—Cr—Mo, for example as specified in ASTM F1537 (and ISO 5832-12). The smooth surfaces may be plasma sprayed with commercially pure titanium, as specified in ASTM F1580, F1978, F1147 and C-633 (and ISO 5832-2). Alternatively, part or all of spacers 100 may be formed with a polymer, for example ultra-high molecular weight polyethylene, UHMWPE, for example as specified in ASTM F648 (and ISO 5834-2). In one embodiment, PEEK-OPTIMA (a trademark of Invibio Ltd Corp, United Kingdom) may be used for one or more components of the disclosed spacers 100. For example, polymeric portions can be formed with PEEK-OPTIMA, which is radiolucent, whereby bony ingrowth may be observed. Other polymeric materials with suitable flexibility, durability, and biocompatibility may also be used.
In accordance with present embodiments, spacer 100 may be provided in various sizes to best fit the anatomy of the patient. Components of matching or divergent sizes may be assembled during the implantation procedure by a medical practitioner as best meets the therapeutic needs of the patient, the assembly inserted within the body using an insertion tool. In some embodiments, spacer 100 may also be provided with an overall angular geometry, for example an angular mating disposition of endplates, to provide for a natural lordosis, or a corrective lordosis, for example of from 0° to 12° for a cervical application, although much different values may be advantageous for other joints. Lordotic angles may also be formed by shaping one or both endplates to have relatively non-coplanar surfaces.
In some embodiments, a single spacer 100 may be used, to provide stabilization for a weakened joint or joint portion. Alternatively, a combination of two, three, or more of any of spacer 100 may be used, at a single joint level, or in multiple joints. Moreover, implants of the disclosure may be combined with other stabilizing means.
In some embodiments, a spacer 100 may be fabricated using material that biodegrades in the body during a therapeutically advantageous time interval, for example after sufficient bone ingrowth has taken place. Further, implants of the disclosure are advantageously provided with smooth and or rounded exterior surfaces, which reduce a potential for deleterious mechanical effects on neighboring tissues.
In some embodiments, a spacer 100 may be provided to be support adjacent vertebrae during flexion/extension, lateral bending, and axial rotation. In one embodiment, spacer 100 is indicated for spinal arthroplasty in treating skeletally mature patients with degenerative disc disease, primary or recurrent disc herniation, spinal stenosis, or spondylosis in the lumbosacral spine (LI-SI). The surgery to implant spacer 100 may be performed through an Anterior, Anterolateral, Posterolateral, Lateral, or any other approach.
The terms “a” or “an”, as used herein, are defined as one or more than one. The term plurality, as used herein, is defined as two or more than two. The term another, as used herein, is defined as at least a second or more. The terms “including” and “having,” as used herein, are defined as comprising (i.e., open language).
Although the present invention and its advantages have been described in detail, it should be understood that various changes, substitutions and alterations may be made herein without departing from the spirit and scope of the invention as defined by the appended claims.
This application is a continuation of U.S. patent application Ser. No. 16/704,643, filed Dec. 5, 2019 (published as U.S. Pat. Pub. No. 2020-0107938), which is a continuation of U.S. patent application Ser. No. 15/613,710, filed on Jun. 5, 2017 (now U.S. Pat. No. 10,524,928), which is a continuation-in-part of U.S. patent application Ser. No. 14/969,376, filed Dec. 15, 2015 (abandoned), which is hereby incorporated by reference in its entirety for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
4349921 | Kuntz | Sep 1982 | A |
4599086 | Doty | Jul 1986 | A |
4863476 | Shepperd | Sep 1989 | A |
4863477 | Monson | Sep 1989 | A |
5123926 | Pisharodi | Jun 1992 | A |
5290312 | Kojimoto et al. | Mar 1994 | A |
5306310 | Siebels | Apr 1994 | A |
5375823 | Navas | Dec 1994 | A |
5390683 | Pisharodi | Feb 1995 | A |
5522899 | Michelson | Jun 1996 | A |
5534030 | Navarro et al. | Jul 1996 | A |
5554191 | Lahille et al. | Sep 1996 | A |
5571192 | Schonhoffer | Nov 1996 | A |
5645596 | Kim | Jul 1997 | A |
5653763 | Errico et al. | Aug 1997 | A |
5665122 | Kambin | Sep 1997 | A |
5676701 | Yuan et al. | Oct 1997 | A |
5800547 | Schafer | Sep 1998 | A |
6039761 | Li et al. | Mar 2000 | A |
6045579 | Hochschuler et al. | Apr 2000 | A |
6080193 | Hochschuler et al. | Jun 2000 | A |
6099531 | Bonutti | Aug 2000 | A |
6126689 | Brett | Oct 2000 | A |
6176882 | Biedermann et al. | Jan 2001 | B1 |
6258125 | Paul et al. | Jul 2001 | B1 |
6527803 | Crozet | Mar 2003 | B1 |
6558423 | Michelson | May 2003 | B1 |
6562074 | Gerbec et al. | May 2003 | B2 |
6576016 | Hochschuler et al. | Jun 2003 | B1 |
6554863 | Paul et al. | Aug 2003 | B2 |
6641614 | Wagner et al. | Nov 2003 | B1 |
6648917 | Gerbec et al. | Nov 2003 | B2 |
6666891 | Boehm, Jr. et al. | Dec 2003 | B2 |
6692495 | Zacouto | Feb 2004 | B1 |
6706070 | Wagner et al. | Mar 2004 | B1 |
6752832 | Ulrich | Jun 2004 | B2 |
6814756 | Michelson | Nov 2004 | B1 |
6830589 | Erickson | Dec 2004 | B2 |
6849093 | Michelson | Feb 2005 | B2 |
6852129 | Gerbec et al. | Feb 2005 | B2 |
6863673 | Gerbec et al. | Mar 2005 | B2 |
6881228 | Zdeblick et al. | Apr 2005 | B2 |
7018415 | McKay | Mar 2006 | B1 |
7070598 | Lim et al. | Jul 2006 | B2 |
7204853 | Gordon | Apr 2007 | B2 |
7217291 | Zucherman et al. | May 2007 | B2 |
7282063 | Cohen et al. | Oct 2007 | B2 |
7316714 | Gordon | Jan 2008 | B2 |
7473276 | Aebi et al. | Jan 2009 | B2 |
7547325 | Biedermann et al. | Jun 2009 | B2 |
7621953 | Braddock, Jr. et al. | Nov 2009 | B2 |
7641693 | Gutlin et al. | Jan 2010 | B2 |
7682396 | Beaurain et al. | Mar 2010 | B2 |
7749270 | Peterman | Jul 2010 | B2 |
7753958 | Gordon | Jul 2010 | B2 |
7771473 | Thramann | Aug 2010 | B2 |
7780732 | Abernathie | Aug 2010 | B2 |
7799081 | McKinley | Sep 2010 | B2 |
7815683 | Melkent et al. | Oct 2010 | B2 |
7837734 | Zucherman et al. | Nov 2010 | B2 |
7875078 | Wysocki et al. | Jan 2011 | B2 |
7901409 | Canaveral et al. | Mar 2011 | B2 |
7909869 | Gordon | Mar 2011 | B2 |
7951199 | Miller | May 2011 | B2 |
7985256 | Grotz et al. | Jul 2011 | B2 |
8062375 | Glerum | Nov 2011 | B2 |
8070813 | Grotz et al. | Dec 2011 | B2 |
8123810 | Gordon | Feb 2012 | B2 |
8137405 | Kostuik et al. | Mar 2012 | B2 |
8192495 | Simpson et al. | Jun 2012 | B2 |
8303663 | Jimenez et al. | Nov 2012 | B2 |
8377140 | DeFalco et al. | Feb 2013 | B2 |
8394129 | Lopez et al. | Mar 2013 | B2 |
8394143 | Grotz et al. | Mar 2013 | B2 |
8435296 | Kadaba et al. | May 2013 | B2 |
8454695 | Grotz et al. | Jun 2013 | B2 |
8647386 | Gordon | Feb 2014 | B2 |
8696751 | Ashley et al. | Apr 2014 | B2 |
8715350 | Janowski | May 2014 | B2 |
8771360 | Jimenez et al. | Jul 2014 | B2 |
8894710 | Simpson et al. | Nov 2014 | B2 |
8932355 | Grotz et al. | Jan 2015 | B2 |
8940049 | Jlmenez et al. | Jan 2015 | B1 |
8956413 | Ashley et al. | Feb 2015 | B2 |
8992620 | Ashley et al. | Mar 2015 | B2 |
9028550 | Shulock et al. | May 2015 | B2 |
9358125 | Jlmenez et al. | Jun 2016 | B2 |
9532883 | McLuen et al. | Jan 2017 | B2 |
9622878 | Grotz | Apr 2017 | B2 |
10105240 | DeFelice | Oct 2018 | B2 |
20020045945 | Liu | Apr 2002 | A1 |
20020068976 | Jackson | Jun 2002 | A1 |
20020068977 | Jackson | Jun 2002 | A1 |
20030176926 | Boehm et al. | Sep 2003 | A1 |
20040030387 | Landry et al. | Feb 2004 | A1 |
20040049271 | Biedermann | Mar 2004 | A1 |
20040054412 | Gerbec et al. | Mar 2004 | A1 |
20040087947 | Lim et al. | May 2004 | A1 |
20040153065 | Lim | Aug 2004 | A1 |
20050021041 | Michelson | Jan 2005 | A1 |
20050021145 | de Villiers et al. | Jan 2005 | A1 |
20050033432 | Gordon | Feb 2005 | A1 |
20050080422 | Otte et al. | Apr 2005 | A1 |
20050113916 | Branch | May 2005 | A1 |
20050149188 | Cook | Jul 2005 | A1 |
20050171541 | Boehm | Aug 2005 | A1 |
20050251258 | Jackson | Nov 2005 | A1 |
20050273171 | Gordon | Dec 2005 | A1 |
20050273174 | Gordon | Dec 2005 | A1 |
20050278026 | Gordon | Dec 2005 | A1 |
20050283244 | Gordon | Dec 2005 | A1 |
20050283245 | Gordon | Dec 2005 | A1 |
20060004453 | Bartish, Jr. et al. | Jan 2006 | A1 |
20060015184 | Winterbottom et al. | Jan 2006 | A1 |
20060058878 | Michelson | Mar 2006 | A1 |
20060084986 | Grinberg et al. | Apr 2006 | A1 |
20060095136 | McLuen | May 2006 | A1 |
20060122701 | Kister | Jun 2006 | A1 |
20060129244 | Ensign | Jun 2006 | A1 |
20060142859 | Mcluen | Jun 2006 | A1 |
20060149385 | Mckay | Jul 2006 | A1 |
20060195192 | Gordon et al. | Aug 2006 | A1 |
20060229729 | Gordon | Oct 2006 | A1 |
20060241770 | Rhoda et al. | Oct 2006 | A1 |
20060253201 | Mcluen | Nov 2006 | A1 |
20070043442 | Abernathie | Feb 2007 | A1 |
20070050030 | Kim | Mar 2007 | A1 |
20070050032 | Gittings et al. | Mar 2007 | A1 |
20070055377 | Hanson et al. | Mar 2007 | A1 |
20070191951 | Branch | Aug 2007 | A1 |
20070255415 | Edie et al. | Nov 2007 | A1 |
20070270963 | Melkent et al. | Nov 2007 | A1 |
20070270968 | Baynham | Nov 2007 | A1 |
20080021559 | Thramann | Jan 2008 | A1 |
20080065222 | Hamada | Mar 2008 | A1 |
20080114467 | Capote et al. | May 2008 | A1 |
20080140207 | Olmos et al. | Jun 2008 | A1 |
20080147194 | Grotz et al. | Jun 2008 | A1 |
20080161933 | Grotz et al. | Jul 2008 | A1 |
20080167657 | Greenhalgh | Jul 2008 | A1 |
20080183204 | Greenhalgh et al. | Jul 2008 | A1 |
20080221694 | Warnick et al. | Sep 2008 | A1 |
20080275455 | Berry et al. | Nov 2008 | A1 |
20080281346 | Greenhalgh et al. | Nov 2008 | A1 |
20080288073 | Renganath et al. | Nov 2008 | A1 |
20080300598 | Barreiro et al. | Dec 2008 | A1 |
20080306488 | Altarac et al. | Dec 2008 | A1 |
20080319487 | Fielding et al. | Dec 2008 | A1 |
20080319549 | Greenhalgh et al. | Dec 2008 | A1 |
20090024217 | Levy et al. | Jan 2009 | A1 |
20090062833 | Song | Mar 2009 | A1 |
20090076616 | Duggal et al. | Mar 2009 | A1 |
20090125062 | Amin | May 2009 | A1 |
20090149956 | Greenhalgh et al. | Jun 2009 | A1 |
20090149959 | Conner et al. | Jun 2009 | A1 |
20090164020 | Janowski | Jun 2009 | A1 |
20090204218 | Richelsoph | Aug 2009 | A1 |
20090222100 | Cipoletti et al. | Sep 2009 | A1 |
20090240334 | Richelsoph | Sep 2009 | A1 |
20090270989 | Conner et al. | Oct 2009 | A1 |
20090281628 | Oglaza et al. | Nov 2009 | A1 |
20090292361 | Lopez | Nov 2009 | A1 |
20090299478 | Carls et al. | Dec 2009 | A1 |
20090312763 | McCormack | Dec 2009 | A1 |
20100049324 | Valdevit | Feb 2010 | A1 |
20100070041 | Peterman | Mar 2010 | A1 |
20100082109 | Greenhalgh et al. | Apr 2010 | A1 |
20100145455 | Simpson et al. | Jun 2010 | A1 |
20100179657 | Greenhalgh et al. | Jul 2010 | A1 |
20100211176 | Greenhalgh | Aug 2010 | A1 |
20100222816 | Gabelberger et al. | Sep 2010 | A1 |
20100286783 | Lechmann et al. | Nov 2010 | A1 |
20110035011 | Cain | Feb 2011 | A1 |
20110093074 | Glerum et al. | Apr 2011 | A1 |
20110160861 | Jimenez et al. | Jun 2011 | A1 |
20110172774 | Varela | Jul 2011 | A1 |
20110276142 | Niemiec et al. | Nov 2011 | A1 |
20110301713 | Theofilos | Dec 2011 | A1 |
20110319997 | Glerum et al. | Dec 2011 | A1 |
20120035729 | Glerum et al. | Feb 2012 | A1 |
20120059470 | Weiman | Mar 2012 | A1 |
20120059472 | Weiman | Mar 2012 | A1 |
20120109308 | Lechmann et al. | May 2012 | A1 |
20120130496 | Duffield et al. | May 2012 | A1 |
20120165945 | Hansell et al. | Jun 2012 | A1 |
20120185049 | Varela | Jul 2012 | A1 |
20120209386 | Triplett et al. | Aug 2012 | A1 |
20120215313 | Saidha et al. | Aug 2012 | A1 |
20120226357 | Varela | Sep 2012 | A1 |
20120265309 | Glerum et al. | Oct 2012 | A1 |
20120277861 | Steele et al. | Nov 2012 | A1 |
20120277870 | Wolters et al. | Nov 2012 | A1 |
20120323329 | Jimenez et al. | Dec 2012 | A1 |
20120330426 | McLaughlin et al. | Dec 2012 | A1 |
20130023993 | Weiman | Jan 2013 | A1 |
20130023994 | Glerum | Jan 2013 | A1 |
20130158663 | Miller et al. | Jun 2013 | A1 |
20130158669 | Sungarian et al. | Jun 2013 | A1 |
20130197647 | Wolters et al. | Aug 2013 | A1 |
20130211526 | Alheidt et al. | Aug 2013 | A1 |
20130274883 | McLuen et al. | Oct 2013 | A1 |
20140067071 | Weiman et al. | Mar 2014 | A1 |
20140088714 | Miller et al. | Mar 2014 | A1 |
20140163683 | Seifert et al. | Jun 2014 | A1 |
20150066145 | Rogers et al. | Mar 2015 | A1 |
20150088258 | Jimenez et al. | Mar 2015 | A1 |
20150134064 | Grotz et al. | May 2015 | A1 |
20150216676 | Shulock et al. | Aug 2015 | A1 |
20150289988 | Ashley et al. | Oct 2015 | A1 |
20150374508 | Sandul | Dec 2015 | A1 |
20160166396 | McClintock | Jun 2016 | A1 |
20160324654 | Loebl et al. | Nov 2016 | A1 |
20170100258 | Jimenez et al. | Apr 2017 | A1 |
20170119543 | Dietzel et al. | May 2017 | A1 |
Number | Date | Country |
---|---|---|
2088066 | Jan 1992 | CA |
4012622 | Jul 1991 | DE |
4327054 | Apr 1995 | DE |
0576379 | Jun 1993 | EP |
0610837 | Jul 1994 | EP |
3111896 | Jan 2017 | EP |
2794968 | Dec 2000 | FR |
2000-513263 | Oct 2000 | JP |
200290058 | Sep 2002 | KR |
1424826 | Sep 1988 | SU |
9201428 | Feb 1992 | WO |
9525485 | Sep 1995 | WO |
1999042062 | Aug 1999 | WO |
1999066867 | Dec 1999 | WO |
2002045625 | Jun 2002 | WO |
2004019829 | Mar 2004 | WO |
2004069033 | Aug 2004 | WO |
2006045094 | Apr 2006 | WO |
2006047587 | May 2006 | WO |
2006113080 | Oct 2006 | WO |
2008044057 | Apr 2008 | WO |
2008134515 | Nov 2008 | WO |
2009114381 | Sep 2009 | WO |
2010103344 | Sep 2010 | WO |
2012031267 | Mar 2012 | WO |
2015009793 | Jan 2015 | WO |
Number | Date | Country | |
---|---|---|---|
20220117750 A1 | Apr 2022 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16704643 | Dec 2019 | US |
Child | 17563470 | US | |
Parent | 15613710 | Jun 2017 | US |
Child | 16704643 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14969376 | Dec 2015 | US |
Child | 15613710 | US |